Bioelectronics Corp (BIEL)

[srinsocal]

BIEL 'Attorney Letter' on file with OTC Markets

As a result of the foregoing, we are of the opinion that:

1. The Disclosures constitute “ adequate current public information” concerning the Issuer’s
securities and the Issuer within the meaning of Rule 144(c)(2).
2. The Disclosures are “available” within the meaning of Rule 144(c)(2).
3. The Disclosures include all of the information that a broker-dealer would be required to
obtain from the Issuer to publish a quotation for the Issuer’s securities under Rule 15c2-11 under the Exchange Act.
4. The Disclosures comply as to form with OTC Markets Group’s Pink Basic Disclosure Guidelines for Providing Adequate Current Disclosure Statement.
5. The Disclosures have been posted through the OTC Disclosure & News Service.

https://www.otcmarkets.com/otcapi/company/financial-report/373623/content